Evidence map›Paper›PMID 42432276›Full record

ArticleAnalytical and bioanalytical chemistry2026

Simultaneous detection of multiple foodborne pathogens using a CRISPR/Cas12a-based pump-free microfluidic chip.

Yachen Tian, Meng Li, Cheng Liu, Tao Liu, Xinglin Zhang, Qing Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yachen TianSchool of Medicine, Linyi University, Shandong, 276000, People's Republic of China.
Meng LiSchool of Medicine, Linyi University, Shandong, 276000, People's Republic of China.
Cheng LiuCollege of Life Sciences, Dezhou University, Dezhou, 253000, People's Republic of China.
Tao LiuSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, People's Republic of China.
Xinglin ZhangSchool of Medicine, Linyi University, Shandong, 276000, People's Republic of China. zhangxinglin@lyu.edu.cn.
Qing LiuSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, People's Republic of China. liuq@usst.edu.cn.ORCID http://orcid.org/0000-0002-5152-2736

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of microfluidic chips for nucleic acid detection provides efficient technical support for monitoring food safety. With the increasing maturity of CRISPR technology, it has the advantages of high specificity and high sensitivity in the detection of single or multiple nucleic acids. In this study, a microfluidic biosensor based on the CRISPR/Cas12a system was constructed using a pump-free microfluidic chip as the carrier, with a focus on the rapid, simultaneous detection of Listeria monocytogenes, Staphylococcus aureus, Escherichia coli O157:H7, and Cronobacter sakazakii. For each target pathogenic bacterium, two replicate channels for each pathogen were established, along with corresponding negative and positive controls, which effectively ensured the reliability and repeatability of the detected results and successfully achieved the simultaneous high-sensitivity, high-specificity, and high-accuracy detection of multiple foodborne pathogens. The detection sensitivity of the sensor for S. aureus, E. coli O157:H7, L. monocytogenes, and C. sakazakii was as low as 10

Indexed as

BacteriaBiosensing TechniquesCRISPR-Cas SystemsFood MicrobiologyMicrofluidic Analytical TechniquesEscherichia coli O157Listeria monocytogenesCRISPR/Cas systemMicrofluidic chipPathogensSimultaneous detection

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.